Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats

Journal of Nuclear Medicine

Volumn 39, Issue 11, 1998, Pages 1944-1951

  Anderson, Carolyn J ^a   Jones, Lynne A ^a   Bass, Laura A ^a   Sherman, Elizabeth L C ^a   McCarthy, Deborah W ^a   Cutler, P Duffy ^a   Lanahan, Margaret V ^a   Cristel, Michael E ^a   Lewis, Jason S ^a   Schwarz, Sally W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Copper 64; Dosimetry; Receptor binding; Somatostatin analog; Targeted radiotherapy

Indexed keywords

1,4,8,11 TETRAAZACYCLOTETRADECANE N,N,N,N TETRAACETIC ACID; COPPER 64; OCTREOTIDE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CANCER INHIBITION; CANCER RADIOTHERAPY; DOSIMETRY; MALE; NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TARGET ORGAN;

ANIMALS; COPPER RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; NEOPLASM TRANSPLANTATION; OCTREOTIDE; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RATS; RATS, INBRED LEW; TISSUE DISTRIBUTION;

EID: 0031797969     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Wiseman GA, Kvols LK. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogs. Semin Nucl Med 1995;25:272-278.
2. Smith-Jones PM, Stolz B, Albert R, et al. Synthesis, radiolabelling, and evaluation of DTPA/octreotide conjugates for radiotherapy. J Lab Compd Radiopharm 1995;37: 499-501.
3. 188Re-RC-160. a directly-radiolabeled somatostutin analogue. Int J Cancer 1996;65:214-220.
4. 211At]astatobenzylguanidine treatment in human medulloblastoma cell lines. J Neuro-Oncol 1995;25:9-17.
5. Kwekkeboom DJ, Kho GS, Lamberts SWJ, Reubi J-C, Laissue JA, Krenning EP. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994;21:1106-1113.
6. 1-octreotide: a case history. Ann N Y Acad Sci 1994;733:496-506.
7. 1-octreotide in midgut carcinoid syndrome. J Nucl Med 1996;37:1519-1521.
8. Stolz B, Smith-Jones P, Albert R, et al. Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer. Digestion 1996;57(suppl 1): 17-21.
9. 3-octreotide in tumor bearing rodents [Abstract]. J Nucl Med 1997;38:18P.
10. 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med 1995;22:608-616.
11. 64Cu labeled monoclonal antibody (MAb) 1A3 as potential agents for radioimmunotherapy [Abstract]. J Nucl Med 1993;34:216P.
12. 64Cu as potential radionuclides for radiotherapy [Abstract]. J Nucl Med 1993;34:134P.
13. 67Cu. Proc Nat Acad Sci USA 1996;93:6814-6818.
14. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol 1996;23:957-980.
15. 64Cu from zinc metal irradiated under boron shielding. Cancer 1994;73:774-778.
16. 64Cu using a biomedical cyclotron. Nucl Med Biol 1997;24:35-43.
17. Anderson CJ, Pajeau TS, Edwards WB, Sherman ELC, Rogers BE, Welch MJ. In vitro and in vivo evaluation of copper-64-labeled octreotide conjugates. J Nucl Med 1995;36:2315-2325.
18. Dehdashti F, Anderson CJ, Trask DD, et al. Initial results with PET imaging using copper-64-labeled TETA-octreotide in patients with carcinoid tumor [Abstract]. J Nucl Med 1997;38:103P.
19. Longnecker DS, Lilja HS, French J, Kuhlmann E, Noll W. Transplantation of azaserine-induced carcinomas of pancreas in rats. Cancer Lett 1979;7:197-202.
20. Raynor K, Reisine T. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. J Pharm Exp Ther 1989;251:510-517.
21. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal Biochem 1980;107:220-239.
22. Cutler PD, Schwarz SW, Anderson CJ, et al. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. J Nucl Med 1995;36:2363-2371.
23. Taylor JE, Theveniau MA, Bashirzadeh R, Reisine T, Eden PA. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides 1994;15:1229-1236.
24. Breeman WAP, Kwekkeboom, DJ, Kooij PPM, et al. Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med 1995;36:623-627.
25. Philpott GW, Schwarz SW, Anderson CJ, et al. RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med 1995;36:1818-1824.
26. Philpott GW, Dehdashti F, Schwarz SW, et al. RadioimmunoPET (MAb-PET) with copper-64-labeled monoclonal antibody (MAb 1A3) fragments [F(ab′)2] in patients with colorectal cancers [Abstract]. J Nucl Med 1995;36:9P.
27. Apelgot S, Coppey J, Gaudemer A, et al. Similar lethal effect in mammalian cells for two radioisotopes of copper with different decay schemes, copper-64 and copper-67. Int J Radiat Biol 1989;55:365-384.
28. 2 fragments. J Clin Invest 1989;83:1449-1456.
29. Kwa HB, Verhoeven AHM, Storm J, Vanzandwijk N, Mooi WJ, Hilkens J. Radioimmunotherapy of small cell lung cancer xenografts using iodine-131-labelled anti-Ncam monoclonal antibody 123c3. Cancer Immunol Immunother 1995;41:169-174.
30. Buchegger F, Rojas A, Delaloye AB, et al. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. Cancer Res 1995;55: 83-89.
31. Meredith RF, Khazaeli MB, Liu T, et al. Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer. J Nucl Med 1992;33:1648-1653.
32. 131I-Lym-1. Cancer Res (suppl) 1990;50:1014s-1016s.
33. Krenning EP, Kooij PPM, Pauwels S, et al. Somatostatin receptors: scintigraphy and radionuclide therapy. Digestion 1996;57(suppl 1):57-61.
34. 1-octreotide. J Nucl Med 1996;37:2002-2006.
35. Duncan JR, Stephenson MT, Wu HP, Anderson CJ. Indium-111-diethylenetriamine-pentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, and hepatocyte lysosomes. Cancer Res 1997;57:659-671.
36. Sharkey RM, Pykett MJ, Siegel JA, Alger EA, Primus FJ, Goldenberg DM. radioimmunotherapy of the GW39 human colonic tumor xenograft with I-131-labeled murine monoclonal antibody to carcinoembryonic antigen. Cancer Res 1987;47:5672-5677.
37. 131I-labelled antibodies and their fragments in the GW-39 colonie cancer xenograft model. Int J Cancer 1989;44:292-300.